197 related articles for article (PubMed ID: 33193304)
21. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
[TBL] [Abstract][Full Text] [Related]
22. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
23. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
Del Papa N; Colombo G; Fracchiolla N; Moronetti LM; Ingegnoli F; Maglione W; Comina DP; Vitali C; Fantini F; Cortelezzi A
Arthritis Rheum; 2004 Apr; 50(4):1296-304. PubMed ID: 15077314
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
[TBL] [Abstract][Full Text] [Related]
25. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways.
Hsu E; Feghali-Bostwick CA
Am J Pathol; 2008 Jun; 172(6):1580-90. PubMed ID: 18467708
[TBL] [Abstract][Full Text] [Related]
27. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.
Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200
[TBL] [Abstract][Full Text] [Related]
28. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.
Lindahl GE; Stock CJ; Shi-Wen X; Leoni P; Sestini P; Howat SL; Bou-Gharios G; Nicholson AG; Denton CP; Grutters JC; Maher TM; Wells AU; Abraham DJ; Renzoni EA
Respir Res; 2013 Aug; 14(1):80. PubMed ID: 23915349
[TBL] [Abstract][Full Text] [Related]
29. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis.
Beon M; Harley RA; Wessels A; Silver RM; Ludwicka-Bradley A
Clin Exp Rheumatol; 2004; 22(6):733-42. PubMed ID: 15638048
[TBL] [Abstract][Full Text] [Related]
30. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Jimenez SA; Piera-Velazquez S
Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
[TBL] [Abstract][Full Text] [Related]
31. Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: A potential multifaceted relationship between OPG/RANKL/TRAIL and Wnt inhibitors.
Taylan A; Birlik M; Kenar G; Toprak B; Gundogdu B; Gurler O; Karakas B; Akıncı B; Sisman AR
Mod Rheumatol; 2019 Jul; 29(4):619-624. PubMed ID: 30001654
[No Abstract] [Full Text] [Related]
32. Serum concentrations of cyclooxygenase-2 in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.
Bassyouni IH; Talaat RM; Salem TA
J Clin Immunol; 2012 Feb; 32(1):124-30. PubMed ID: 21979415
[TBL] [Abstract][Full Text] [Related]
33. A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis.
Takahashi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Toyama T; Taniguchi T; Yoshizaki A; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2016 Dec; 175(6):1195-1203. PubMed ID: 27105895
[TBL] [Abstract][Full Text] [Related]
34. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
[TBL] [Abstract][Full Text] [Related]
35. Elevated Fibronectin Levels in Profibrotic CD14
Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
Front Immunol; 2021; 12():642891. PubMed ID: 34504485
[TBL] [Abstract][Full Text] [Related]
36. Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding.
Kavian N; Marut W; Servettaz A; Nicco C; Chéreau C; Lemaréchal H; Guilpain P; Chimini G; Galland F; Weill B; Naquet P; Batteux F
Arthritis Rheumatol; 2015 Jul; 67(7):1881-90. PubMed ID: 25776044
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
39. CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
Taniguchi T; Miyagawa T; Toyama S; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2018 Sep; 27(9):1030-1037. PubMed ID: 29947047
[TBL] [Abstract][Full Text] [Related]
40. Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic Sclerosis.
Zhang Y; Zhu H; Layritz F; Luo H; Wohlfahrt T; Chen CW; Soare A; Bergmann C; Ramming A; Groeber F; Reuter C; Fornasini G; Soukhareva N; Schreiber B; Ramamurthy S; Amann K; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Aug; 72(8):1385-1395. PubMed ID: 32182396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]